2023
DOI: 10.1016/j.abb.2023.109535
|View full text |Cite
|
Sign up to set email alerts
|

Ferrostatin-1 improves BMSC survival by inhibiting ferroptosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 12 publications
(10 citation statements)
references
References 27 publications
0
4
0
Order By: Relevance
“…45 LPS negatively regulates AMPK, whereas Fer-1 induces AMPK phosphorylation. 46 Therefore, the micelles may boost IL-10 release via activating AMPK. Altogether, ferroptosis inhibition by radical trapping micelles could essentially mitigate inflammation at the cellular level (Figure 3g).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…45 LPS negatively regulates AMPK, whereas Fer-1 induces AMPK phosphorylation. 46 Therefore, the micelles may boost IL-10 release via activating AMPK. Altogether, ferroptosis inhibition by radical trapping micelles could essentially mitigate inflammation at the cellular level (Figure 3g).…”
Section: Resultsmentioning
confidence: 99%
“…Previous work showed that the phosphorylation of AMP-activated protein kinase (AMPK) could trigger IL-10 production . LPS negatively regulates AMPK, whereas Fer-1 induces AMPK phosphorylation . Therefore, the micelles may boost IL-10 release via activating AMPK.…”
Section: Resultsmentioning
confidence: 99%
“…Moreover, ferroptosis of hUCMSCs is reduced by regulating the CSE/H 2 S pathway, which improves vascular remodeling in mice with hypoxia-induced PAH via maintaining the balance between stem cell maintenance and differentiation[ 10 ]. While genetic modification of stem cells for CSE expression is an efficient way of preconditioning the cells against ferroptosis, alternative preconditioning strategies may also be exploited[ 29 , 39 , 40 ].…”
Section: Introductionmentioning
confidence: 99%
“…However, although hucMSCs have achieved good efficacy in clinical trials, we still face great challenges. Differences in oxygen concentration and nutritional conditions between in vivo and in vitro may subject hucMSCs to high oxidative stress after transplantation in vivo, reducing colonization and survival rates and preventing effective treatment of damaged sites [ 35 , 7 , 8 ]. Therefore, it is particularly important to explore the molecular mechanisms that cause oxidative stress in hucMSCs, find intervening targets, and genetically modify MSCs to improve therapeutic efficacy in pediatric diseases.…”
Section: Introductionmentioning
confidence: 99%